Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Clin Sci (Lond). 2014 Dec;127(11):645–654. doi: 10.1042/CS20140030

Table 2.

Blood pressure and circulating factors during placebo and salsalate

Variable Young Non-exercising
Older Non-exercising
Older Exercise-Trained
Placebo Salsalate Placebo Salsalate Placebo Salsalate
SBP (mm Hg) 110 ± 4 109 ± 3 122 ± 4 117 ± 4 111 ± 4 111 ± 4
DBP (mm Hg) 61 ± 3 58 ± 2 73 ± 3 * 71 ± 3 69 ± 2 * 70 ± 2
Total cholesterol (mg/dL) 142 ± 7 126 ± 6 * 182 ± 7 * 163 ± 5 186 ± 9 * 167 ± 9
LDL-cholesterol (mg/dL) 79 ± 7 73 ± 5 114 ± 5 * 102 ± 5 113 ± 7 * 107 ± 8
HDL-cholesterol (mg/dL) 47 ± 3 43 ± 3 47 ± 3 49 ± 3 49 ± 4 48 ± 3
Triglycerides (mg/dL) 58 ± 2 50 ± 4 104 ± 13 * 59 ± 4 106 ± 12 * 64 ± 6
Glucose (mg/dL) 87 ± 2 83 ± 2 89 ± 2 84 ± 2 86 ± 1 82 ± 2
C-reactive protein (mg/L) 0.5 ± 0.1 0.7 ± 0.2 1.0 ± 0.2 1.2 ± 0.2 0.6 ± 0.1 0.7 ± 0.1
Interleukin-6 (pg/mL) 0.8 ± 0.1 1.0 ± 0.2 1.4 ± 0.3 1.2 ± 0.2 0.8 ± 0.1 0.6 ± 0.1
TNFα (pg/ml) 0.8 ± 0.1 0.8 ± 0.0 1.1 ± 0.1 1.3 ± 0.1 1.0 ± 0.1 1.0 ± 0.1

Data are mean ± SE. SBP, systolic blood pressure; DBP, diastolic blood pressure; TNFα, tumor necrosis factor alpha.

*

P<0.05 vs. young non-exercising placebo,

P<0.05 vs. older non-exercising placebo,

P<0.05 vs. older trained placebo